Investigation of the potential of a 48 kDa protein as a vaccine candidate for infection against nontypable Haemophilus influenzae

Vaccine

Volumn 25, Issue 20, 2007, Pages 4012-4019

  Webb, Dianne C ^a   Otczyk, Diana C ^b   Cripps, Allan W ^b  

^a Biology and Environment   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

48 kDa protein; HI0164; Lung; Nontypable Haemophilus influenzae; Otitis media; Vaccine

Indexed keywords

HAEMOPHILUS INFLUENZAE VACCINE; PROTEIN P48; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIABILITY; BACTERIUM ISOLATE; BIOTYPE; CHILD; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN TISSUE; MALE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ADULT; AGED; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; BACTERIAL PROTEINS; CHILD; CHILD, PRESCHOOL; CLONING, MOLECULAR; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS VACCINES; HUMANS; INFANT; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RATS; RATS, WISTAR; SEQUENCE ALIGNMENT; VACCINES, SYNTHETIC;

EID: 34247379914     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.02.048     Document Type: Article

References (32)

1. Murphy T.F., and Apicella M.A. Nontypable Haemophilus influenzae: a review of clinical aspects, surface antigens, and the immune response to infection. Rev Infect Dis 9 (1987) 1-15
2. Teele D.J., Klein J.O., and Rosner B. Epidemiology of otitis media during the first 7 years of life in children in greater Boston: a prospective, cohort study. J Infect Dis 160 (1989) 83-94
3. Luotonen M., Uhari M., Aitola L., Lukkaroinen A.M., Luotonen J., Uhari M., et al. Recurrent otitis media during infancy and linguistic skills at the age of 9 years. Pediatr Infect Dis J 15 10 (1996) 854-858
4. Pichichero M.E., and Pichichero C.L. Persistent acute otitis media: I. Causative pathogens. Pediatr Infect Dis J 14 3 (1995) 178-183
5. Bernstein J., Brodsky L., Stanievich J., and Ogra P.L. Effect of prior antibiotic treatment on middle ear disease in children. Ann Otol Rhinol Laryngol 1001 (1992) 87-91
6. Forsgren J., Samuelson A., Ahlin A., Jonasson J., Rynnel-Dagoo B., and Lindberg A. Haemophilus influenzae resides and multiplies intracellularly in human adenoid tissue as demonstrated by in situ hybridization and bacterial viability assay. Infect Immun 62 (1994) 673-679
7. Manolis E. Alterations to the oropharyngeal and nasopharyngeal microbial flora of children after tonsillectomy and adenoidectomy. J Laryngol Otol 108 (1994) 763-767
8. Murphy T.F., Bakaketz L.O., Kyd J.M., Watson B., and Klein D.L. Vaccines for otitis media: proposals for overcoming obstacles to progress. Vaccine 23 (2005) 2696-2702
9. Dunkley M., Pabst R., and Cripps A. An important role for intestinally derived T cells in respiratory defence. Immunol Today 16 (1995) 231-236
10. Pilette C., Ouadrhiri Y., Godding V., Vaerman J.P., and Sibille Y. Lung mucosal immunity: immunoglobulin-A revisited. Eur Respir J 18 3 (2001) 571-588
11. Prymula R., Peeters P., Chrobok V., Kriz P., Novakova E., Kaliskova E., et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 367 (2006) 740-748
12. Cripps A.W., and Otczyk D.C. Prospects for a vaccine against otitis media. Expert Rev Vaccines 5 4 (2006) 517-534
13. Fleischmann R.D., Adams M.D., White O., Clayton R.A., Kirkness E.F., Kerlavage A.R., et al. Whole-genome random sequencing and assembley of Haemophilus influenzae Rd. Science 269 (1995) 496-512
14. Webb D.C., and Cripps A.W. Secondary structure and molecular analysis of interstrain variability in the P5 outer-membrane protein of non-typable Haemophilus influenzae isolated from diverse anatomical sites. J Med Microbiol 47 (1998) 1059-1067
15. Butt H.L., Taylor D.C., Cripps A.W., Clancy R.L., Murree-Allen K., Hensley M.J., et al. Biotyping respiratory Haemophilus species with the microbact system. Pathology 20 3 (1988) 253-255
16. Taylor D.C., Cripps A.W., Clancy R.L., Murree-Allen K., Hensley M.J., Saunders N.A., et al. Biotypes of Haemophilus parainfluenzae from the respiratory secretions in chronic bronchitis. J Med Microbiol 36 4 (1992) 279-282
17. Devereux J., Haeberli P., and Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res 12 1 Pt 1 (1984) 387-395
18. Webb D.C., and Cripps A.W. A P5 peptide that is homologous to peptide 10 of OprF from Pseudomonas aeruginosa enhances clearance of nontypeable Haemophilus influenzae from acutely infected rat lung in the absence of detectable peptide-specific antibody. Infect Immun 68 (2000) 377-381
19. Webb D.C., and Cripps A.W. Immunization with recombinant transferrin binding protein B enhances clearance of nontypeable Haemophilus influenzae from the rat lung. Infect Immun 67 (1999) 2138-2144
20. Murphy T.F., and Bartos L.C. Human bactericidal antibody response to outer membrane P2 of nontypable Haemophilus influenzae. Infect Immun 56 (1988) 2673-2679
21. Carlone G.M., Thomas M.L., Rumschlag H.S., and Sottnek F.O. Rapid microprocedure for isolating detergent-insoluble outer membrane proteins from Haemophilus species. J Clin Microbiol 24 (1986) 330-332
22. Cruz W.T., Nedialkov Y.A., Thacker B.J., and Mulks M.H. Molecular characterization of a common 48-kilodalton outer membrane protein of Actinobacillus pleuropneumoniae. Infect Immun 64 1 (1996) 83-90
23. Blake M.S., and Gotschlich E.C. Purification and partial characterization of the opacity-associated proteins of Neisseria gonorrhoeae. J Exp Med 159 2 (1984) 452-462
24. Chopra I., and Shales S.W. Comparison of the polypeptide composition of Escherichia coli outer membranes prepared by two methods. J Bacteriol 144 1 (1980) 425-427
25. Thomas L.D., Kyd J.M., Bastin D.A., Dunkley M.L., and Cripps A.W. Immunisation with non-integral OMPs promotes pulmonary clearance of Pseudomonas aeruginosa. FEMS Immunol Med Microbiol 37 2-3 (2003) 155-160
26. Wallace F.J., Cripps A.W., Clancy R.L., Husband A.J., and Witt C.S. A role for intestinal T lymphocytes in bronchus mucosal immunity. Immunology 74 (1991) 68-73
27. Malley R., Trzcinski K., Srivastava A., Thompson C.M., Anderson P.W., and Lipsitch M. CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci USA 102 13 (2005) 4848-4853
28. Hayashi M., Nakayama Y., and Unemoto T. Existence of Na+-translocating NADH-quinone reductase in Haemophilus influenzae. FEBS Lett 381 3 (1996) 174-176
29. Lucas B., Bumann D., Walduck A., Koesling J., Develioglu L., Meyer T.F., et al. Adoptive transfer of CD4+ T cells specific for subunit A of Helicobacter pylori urease reduces H. pylori stomach colonization in mice in the absence of interleukin-4 (IL-4)/IL-13 receptor signaling. Infect Immun 69 3 (2001) 1714-1721
30. Aebischer T., Fischer A., Walduck A., Schlotelburg C., Lindig M., Schreiber S., et al. Vaccination prevents Helicobacter pylori-induced alterations of the gastric flora in mice. FEMS Immunol Med Microbiol 46 2 (2006) 221-229
31. Faden H., Bernstein J., Brodsky L., Stanievich J., Drystofik D., Shuff C., et al. Otitis media in children. I. The systemic immune response to nontypable Haemophilus influenzae. J Infect Dis 160 (1989) 999-1004
32. Kyd J.M., and Cripps A.W. Towards a protein vaccine for nontypeable Haemophilus influenzae. Clin Infect Dis 28 (1999) 238